85974-15-8

Basic information

• Product Name: t-butoxycarbonyl-β-benzyl-L-aspartyl-L-phenylalanine 4-picolyl ester
• CAS NO: 85974-15-8
• Molecular Weight: 561.635
• Mol File: 85974-15-8.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: t-butoxycarbonyl-β-benzyl-L-aspartyl-L-phenylalanine 4-picolyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: t-butoxycarbonyl-β-benzyl-L-aspartyl-L-phenylalanine 4-picolyl ester(85974-15-8)
• EPA Substance Registry System: t-butoxycarbonyl-β-benzyl-L-aspartyl-L-phenylalanine 4-picolyl ester(85974-15-8)

Safety Data

• Hazardous Substances Data: 85974-15-8(Hazardous Substances Data)

Upstream product

• 83031-02-1 t-butoxycarbonyl-L-phenylalanine 4-picolyl ester 
• 84891-23-6 L-phenylalanine 4-picolyl ester 
• 7536-58-5 BOC-L-aspartic acid 4-benzyl ester 

Downstream Products

• 85974-18-1 t-butoxycarbonyl-ε-benzyloxycarbonyl-L-lysyl-β-benzyl-L-aspartyl-L-glutaminyl-β-benzyl-L-aspartyl-L-phenylalanine 4-picolyl ester 
• 85974-22-7 t-butoxycarbonyl-ε-benzyloxycarbonyl-L-lysyl-L-histidyl-L-glutaminyl-β-benzyl-L-aspartyl-L-phenylalanine 4-picolyl ester 
• 85974-21-6 N,N^Im-di-t-butoxycarbonyl-L-histidyl-L-glutaminyl-β-benzyl-L-aspartyl-L-phenylalanine 4-picolyl ester 
• 85974-17-0 t-butoxycarbonyl-β-benzyl-L-aspartyl-L-glutaminyl-β-benzyl-L-aspartyl-L-phenylalanine 4-picolyl ester 
• 85974-16-9 t-butoxycarbonyl-L-glutaminyl-β-benzyl-L-aspartyl-L-phenylalanine 4-picolyl ester 
• 85974-24-9 t-butoxycarbonyl-O-benzyl-L-seryl-ε-benzyloxycarbonyl-L-lysyl-L-histidyl-L-glutaminyl-β-benzyl-L-aspartyl-L-phenylalanine 4-picolyl ester 

Relevant articles and documents

Amino-acids and Peptides Part 47. Synthesis of Peptides Related to Bovine Prothrombin.

It is known that Fragment 2 of bovine prothrombin inhibits the coagulation of blood plasma, and various considerations suggest that the inhibitory site might be in the 198-215 region (1) of prothrombin.Peptides related to the sequences in the 202-215 region of bovine prothrombin (2) have been synthesised by the picolyl ester method for examination as possible anticoagulation agents, including the bovine fragment 202-215 and the human fragment 204-215, variants of the sequence 210-215, and the bovine and human sequences 202-209.